While still a couple of years out, MD+DI gained some insights into Dexcom's next-generation sensor from an interview with the ...
SINGAPORE - Patients with rarer types of diabetes, including those caused by cancer, can now benefit from government subsidies of up to 80 per cent, which would almost halve their monthly costs spent ...
[Image from Diabeloop on LinkedIn] Diabeloop announced today that its DBLG2 algorithm for automated insulin delivery has received FDA 510(k) clearance. DBLG2 received authorization as a Class II ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results